AstraZeneca is a global, innovation-driven biopharmaceutical business with a focus on the discovery, development, and commercialization of primary and specialty care medicines that transform lives. Our primary focus is on four important areas of healthcare: Cardiovascular, Renal, and Metabolic disease (CVRM); Oncology; Respiratory and Immunology; and Rare Diseases. AstraZeneca operates in more than 100 countries and its innovative medicines are used by millions of patients worldwide. In Canada, we employ roughly 1,090 employees across the country and our headquarters are located in Mississauga, Ontario. The company invested $112 million in Canadian research and development in 2020 and is designated a Global Clinical Trial Delivery site – leading the delivery of more than 100 global clinical trials in oncology and respiratory disease.